scholarly article | Q13442814 |
P2093 | author name string | John Kasckow | |
Sidney Zisook | |||
Lauren Fox | |||
Lori Montross | |||
Laurie Prunty | |||
P2860 | cites work | Interventions for depressed elderly primary care patients | Q58391664 |
Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity | Q59668672 | ||
Suicide behaviour over 18 months in recent onset schizophrenic patients: The effects of CBT | Q59784180 | ||
The Iowa 500: suicide in mania , depression, and schizophrenia | Q66921036 | ||
Risk factors for suicide among patients with schizophrenia | Q68527816 | ||
Patterns of self-destructive behaviour in schizophrenia | Q69534526 | ||
Mortality in schizophrenia. A ten-year follow-up based on the Stockholm County inpatient register | Q69538086 | ||
Suicide in Chronic Schizophrenia | Q72534176 | ||
Suicidality and substance misuse in first-admitted subjects with psychotic disorder | Q73187020 | ||
Suicide Risk in Placebo vs Active Treatment in Placebo-Controlled Trials for Schizophrenia | Q73270020 | ||
The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia | Q74404689 | ||
Treatment of schizophrenia 1999. The expert consensus guideline series | Q77918229 | ||
Relapse prevention and recovery in the treatment of schizophrenia | Q79842985 | ||
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study | Q82593050 | ||
[Influence of positive and negative symptoms on suicidal behaviour in schizophrenia. Review of current literature] | Q82764297 | ||
The Lifetime Risk of Suicide in Schizophrenia | Q22253035 | ||
Suicide as an outcome for mental disorders. A meta-analysis | Q28244203 | ||
Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome | Q28268543 | ||
Suicide among patients with schizophrenia: a consideration of risk and protective factors | Q28293391 | ||
Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation | Q28307938 | ||
Schizophrenia--a high-risk factor for suicide: clues to risk reduction | Q30312094 | ||
Schizophrenics kill themselves too: a review of risk factors for suicide | Q30451676 | ||
Suicide and schizophrenia: data from a prospective community treatment study | Q30583560 | ||
Do antipsychotic medications decrease the risk of suicide in patients with schizophrenia? | Q33540378 | ||
Remission in depressed geriatric primary care patients: a report from the PROSPECT study | Q33579484 | ||
Substance use disorders in schizophrenia: review, integration, and a proposed model | Q33865680 | ||
Suicide attempts and associated factors in older adults with schizophrenia | Q33893234 | ||
Psychotherapy and recovery from schizophrenia: A review of potential applications and need for future study | Q33893244 | ||
Practice guideline for the treatment of patients with schizophrenia, second edition. | Q33976372 | ||
Where schizophrenic patients commit suicide: a review of suicide among inpatients and former inpatients | Q33990881 | ||
The management of suicidality: assessment and intervention | Q34064574 | ||
Mortality in schizophrenia: a measurable clinical endpoint | Q34183484 | ||
Suicide and schizophrenia | Q34305454 | ||
Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study | Q34571739 | ||
Elderly patients with schizophrenia and depression: diagnosis and treatment | Q34707472 | ||
Treatment of Subsyndromal Depressive Symptoms in Middle-Age and Older Patients With Schizophrenia: Effect of Age on Response | Q34819160 | ||
Co-occurring depressive symptoms in the older patient with schizophrenia | Q35008098 | ||
Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: relationship to functioning and Quality of Life | Q35055345 | ||
The interpersonal theory of suicide | Q35088289 | ||
Maximizing the synergy between pharmacotherapy and psychosocial therapies for schizophrenia | Q35102485 | ||
Suicide and schizophrenia: a review of literature for the decade (1990-1999) and implications for mental health nursing | Q35122924 | ||
Case-control study of the relationship of depressive symptoms to suicide in a community-based sample of individuals with schizophrenia in China | Q35150505 | ||
Clinical and health services relationships between major depression, depressive symptoms, and general medical illness | Q35189628 | ||
Depression and cardiovascular disease: mechanisms of interaction | Q35189643 | ||
Integrated treatment of schizophrenia | Q35576671 | ||
Antisuicide properties of psychotropic drugs: a critical review | Q35668658 | ||
Suicide risk in schizophrenia: learning from the past to change the future | Q35738863 | ||
Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine. | Q36091773 | ||
Schizophrenia and suicide: systematic review of risk factors | Q36182528 | ||
Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations | Q36183115 | ||
Developing psychological perspectives of suicidal behaviour and risk in people with a diagnosis of schizophrenia: we know they kill themselves but do we understand why? | Q36710460 | ||
Managing suicidality in schizophrenia | Q36933486 | ||
Suicide risk in schizophrenia: explanatory models and clinical implications, The Schematic Appraisal Model of Suicide (SAMS). | Q36962311 | ||
Cognitive-behavioral interventions to reduce suicide behavior: a systematic review and meta-analysis | Q37039395 | ||
Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups. | Q37061576 | ||
Vascular factors and depression | Q37152050 | ||
Suicide within 12 months of contact with mental health services: national clinical survey | Q37449041 | ||
Diagnosis of secondary depression in schizophrenia: implications for DSM-IV. | Q37755444 | ||
Depression, attempted suicide, and suicide in patients with chronic schizophrenia | Q38161346 | ||
Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial | Q38383845 | ||
'Akinetic Depression' in Schizophrenia | Q39206918 | ||
Conditions predisposing to suicide: a review | Q39619249 | ||
Suicide among schizophrenics: a review | Q39813674 | ||
Command hallucinations in outpatients with schizophrenia | Q40413899 | ||
Cognitive approach to depression and suicidal thinking in psychosis. 2. Testing the validity of a social ranking model | Q40736157 | ||
Explaining the gender difference in depressive symptoms | Q41704213 | ||
Suicidality before and in the early phases of first episode psychosis | Q43095829 | ||
Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial | Q43111012 | ||
San Diego Suicide Study. III. Relationships between diagnoses and stressors | Q43647590 | ||
Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database | Q43726217 | ||
A study of suicide in schizophrenic in-patients | Q43965320 | ||
Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. | Q44029969 | ||
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). | Q44268852 | ||
San Diego Suicide Study. II. Substance abuse in young cases | Q44303203 | ||
Suicidal ideation in patients with schizophrenia | Q44588355 | ||
International Multisite Double-Blind Trial of the Atypical Antipsychotics Risperidone and Olanzapine in 175 Elderly Patients With Chronic Schizophrenia | Q44650318 | ||
Reducing the risk for suicide in schizophrenia and affective disorders | Q44662799 | ||
Observations on suicide in chronic schizophrenics | Q44696663 | ||
Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial | Q44783938 | ||
Suicidal ideation and suicide attempts among middle-aged and older patients with schizophrenia spectrum disorders and concurrent subsyndromal depression | Q46086521 | ||
Risk factors for completed suicide in schizophrenia. | Q46487086 | ||
Risk factors of suicide among schizophrenics. | Q47344164 | ||
OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. | Q47345355 | ||
Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment | Q47351642 | ||
Depression, hopelessness and suicide in chronic schizophrenia | Q47356589 | ||
Discovering the neural basis of human social anxiety: a diagnostic and therapeutic imperative | Q48102710 | ||
The early course of schizophrenia and depression*. | Q48823951 | ||
Psychological autopsy of completed suicide in children and adolescents | Q49201340 | ||
Vulnerability factors in Sylvia Plath's suicide | Q50253844 | ||
Factors predicting suicide in psychotic patients. | Q50544207 | ||
The 15-year outcome of Chinese patients with schizophrenia in Hong Kong. | Q50862532 | ||
Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. | Q50936677 | ||
Life satisfaction and suicidal attempts among persons with schizophrenia | Q51015049 | ||
Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. | Q51026926 | ||
Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. | Q51068243 | ||
Cognitive behavioral therapy reduces suicidal ideation in schizophrenia: results from a randomized controlled trial. | Q51902335 | ||
Reducing suicidal ideation in depressed older primary care patients. | Q51911527 | ||
Depression in the long-term course of schizophrenia. | Q51928374 | ||
Suicide attempts amongst elderly schizophrenia patients: a 10-year case-control study. | Q51937343 | ||
Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. | Q51956472 | ||
Mental disorder in elderly suicides: a case-control study. | Q51959370 | ||
Mental disorders and cause-specific mortality. | Q51961731 | ||
Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression. | Q51971734 | ||
Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. | Q51985870 | ||
Mental disorders in elderly suicide. | Q52019510 | ||
Suicide rates among public mental health patients. | Q52097833 | ||
Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial. | Q53360074 | ||
Functional impairment in older schizophrenic persons. Toward a conceptual model. | Q53516819 | ||
Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. | Q53589905 | ||
Critical treatment issues in suicide among schizophrenics. | Q53812243 | ||
Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with Schizophrenia in Quebec and Saskatchewan: A retrospective database study | Q57589554 | ||
P433 | issue | 3 | |
P921 | main subject | suicide prevention | Q3298118 |
suicide | Q10737 | ||
schizophrenia | Q41112 | ||
suicide risk | Q47319077 | ||
P304 | page(s) | 379-393 | |
P577 | publication date | 2011-06-01 | |
P1433 | published in | Aging Health | Q15751271 |
P1476 | title | Suicidal behavior in the older patient with schizophrenia | |
P478 | volume | 7 |
Search more.